Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
Polar Power Inc

Start price
Target price
Perf. (%)
€0.43
18.12.23
-
18.12.24
1.76%
03.07.24

StockNews.com 
18.12.23 50%
sell
Rubicon Technology

Start price
Target price
Perf. (%)
€0.57
16.12.23
-
16.12.24
9.65%
08.07.24

StockNews.com 
16.12.23 50%
buy
Moleculin Biotech Inc

Start price
Target price
Perf. (%)
€0.56
14.12.23
€2.74
14.12.24
-26.13%
21.03.24

HC Wainwright 
14.12.23 50%
buy
Inotiv Inc.

Start price
Target price
Perf. (%)
€2.16
12.12.23
€23.18
12.12.24
-26.39%
08.07.24

Craig Hallum 
12.12.23 50%
buy
Altimmune

Start price
Target price
Perf. (%)
€5.09
12.12.23
-
12.12.24
30.56%
13.05.24

Could be worthwhile Investment >10% per year
daimler1 
12.12.23 50%
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€13.80
10.12.23
€40.00
10.12.24
-19.13%
26.03.24

Could be very worthwhile Investment >20% year
Rising EBIT margin expected
High Investments for future growth
Very valuable balance sheet
WatchMen 
10.12.23 50%
sell
Advaxis Inc.

Start price
Target price
Perf. (%)
€0.059
10.12.23
-
10.12.24
-
23.09.22

StockNews.com 
10.12.23 50%
sell
Energy Focus Inc.

Start price
Target price
Perf. (%)
€1.51
10.12.23
-
10.12.24
-22.52%
08.07.24

StockNews.com 
10.12.23 50%
sell
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€0.68
10.12.23
-
10.12.24
-62.30%
08.07.24

StockNews.com 
10.12.23 50%
sell
Polar Power Inc

Start price
Target price
Perf. (%)
€0.43
10.12.23
-
10.12.24
2.12%
03.07.24

StockNews.com 
10.12.23 50%
sell
Altimmune

Start price
Target price
Perf. (%)
€7.40
09.12.23
€1.00
09.12.24
29.19%
09.02.24

overvalued
negative Cash Flow expected
Very little Investments for future growth
Risky balance sheet
Marianka 
09.12.23 70%
buy
Altimmune

Start price
Target price
Perf. (%)
€7.40
09.12.23
€13.00
09.12.24
15.03%
04.02.24

overvalued
negative Cash Flow expected
Probably not worthwhile Investment
Revenue decline/stagnation expected
dimontalban 
09.12.23 60%
buy
Applied DNA Sciences Inc.

Start price
Target price
Perf. (%)
€0.82
08.12.23
€1.86
08.12.24
-73.57%
24.04.24

HC Wainwright 
08.12.23 50%
buy
Hudson Technolgies Inc.

Start price
Target price
Perf. (%)
€3.10
05.12.23
€15.69
05.12.24
-
30.09.21

B. Riley 
05.12.23 50%
buy
Kirkland S Inc.

Start price
Target price
Perf. (%)
€3.12
04.12.23
€6.47
04.12.24
-45.83%
21.06.24

Benchmark Co. 
04.12.23 50%
sell
Evoke Pharma Inc.

Start price
Target price
Perf. (%)
€1.24
04.12.23
-
04.12.24
-60.65%
08.07.24

StockNews.com 
04.12.23 50%
sell
Digital Ally Inc.new

Start price
Target price
Perf. (%)
€6.60
03.12.23
-
03.12.24
0.00%
09.02.24

StockNews.com 
03.12.23 50%
sell
Advaxis Inc.

Start price
Target price
Perf. (%)
€0.059
02.12.23
-
02.12.24
-
23.09.22

StockNews.com 
02.12.23 50%
sell
Energy Focus Inc.

Start price
Target price
Perf. (%)
€1.48
02.12.23
-
02.12.24
-20.95%
08.07.24

StockNews.com 
02.12.23 50%
sell
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€0.68
02.12.23
-
02.12.24
-28.56%
08.07.24

StockNews.com 
02.12.23 50%
sell
Polar Power Inc

Start price
Target price
Perf. (%)
€0.48
02.12.23
-
02.12.24
-9.38%
03.07.24

StockNews.com 
02.12.23 50%
sell
Altimmune

Start price
Target price
Perf. (%)
€3.45
02.12.23
€1.00
02.12.24
114.68%
09.12.23

overvalued
negative Cash Flow expected
Very little Investments for future growth
Risky balance sheet
Marianka 
02.12.23 50%
sell
Altimmune

Start price
Target price
Perf. (%)
€3.45
02.12.23
€1.00
02.12.24
114.68%
09.12.23

overvalued
negative Cash Flow expected
Probably not worthwhile Investment
Revenue decline/stagnation expected
dimontalban 
02.12.23 70%
buy
Altimmune

Start price
Target price
Perf. (%)
€3.50
01.12.23
€13.77
01.12.24
79.60%
16:34

HC Wainwright 
01.12.23 50%
sell
Rubicon Technology

Start price
Target price
Perf. (%)
€0.54
30.11.23
-
30.11.24
16.82%
08.07.24

StockNews.com 
30.11.23 50%